DEFINE-HT Study Shows Prospera™ Heart Predicts Outcomes Better Than Biopsy
DEFINE-HT Clinical Trial Shows Prospera™ Heart Accurately Predicts Outcomes and Outperforms Biopsy in Heart Transplant Surveillance Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, has announced the results of its landmark DEFINE-HT clinical trial,…
Mirion Reports Q1 2025 Financial Results and Revises Full-Year Outlook
Mirion Reports Strong First Quarter 2025 Results and Updates Full-Year Guidance Amid Robust Market Demand Mirion Technologies, Inc. (“Mirion” or the “Company”) (NYSE: MIR), a leading provider of radiation detection, measurement, analysis, and monitoring technologies serving nuclear, medical, defense, and…
Guardant Health Showcases Shield Test’s Accuracy Across 10 Cancers
Guardant Health Unveils Compelling Data on Shield Multi-Cancer Detection Test at AACR 2025, Showcasing High Specificity and Sensitivity Across Ten Tumor Types Guardant Health, Inc. (Nasdaq: GH), a prominent leader in precision oncology, has released new clinical data demonstrating the…
Microba Achieves Breakthrough in IBD Research and Secures Major Gastroenterology Partnership
Microba Life Sciences Achieves Breakthrough in IBD Diagnostics and Forms Strategic Partnership with Leading Gastroenterology Provider Microba Life Sciences Limited (ASX: MAP), a precision microbiome company at the forefront of next-generation diagnostics, today announced two major milestones that reinforce its…
D3 Bio Showcases D3S-001 as Promising KRAS G12C Inhibitor in Nature Medicine and AACR 2025
D3 Bio Showcases Next-Generation KRAS G12C Inhibitor D3S-001 in Nature Medicine and AACR 2025 Presentation, Demonstrating Breakthrough Efficacy and Resistance Overcoming Potential D3 Bio, a clinical-stage biotechnology company at the forefront of precision oncology innovation, has announced a major milestone…
NIH’s Shift Toward Human-Based Research Hailed as Major Victory for Animal Welfare
NIH’s Commitment to Human-Based Research Applauded as a Major Milestone for Science and Animal Welfare The Physicians Committee for Responsible Medicine, a nonprofit organization committed to advancing ethical medical research and improving public health, is celebrating what it calls a…
Swisslog Healthcare Expands AutoPack Capabilities with New Complementary Features
Swisslog Healthcare Enhances AutoPack™ System with New Features to Boost Efficiency and Flexibility in Hospital Pharmacies Swisslog Healthcare, a global leader in pharmacy automation and transport solutions, has unveiled a suite of new features designed to further improve the capabilities…
InVitria Unveils Groundbreaking Optibumin® 25 for Closed-System Biomanufacturing Applications
InVitria Launches Optibumin® 25: A Groundbreaking 25% Recombinant Human Serum Albumin Designed for Closed-System Biomanufacturing InVitria, a recognized innovator in the development of recombinant, chemically defined components for biomanufacturing, has announced the commercial launch of Optibumin® 25 — a first-of-its-kind…
California Center for Reproductive Health Named Top U.S. Fertility Clinic by Newsweek for Third Year
California Center for Reproductive Health Recognized by Newsweek as One of America’s Best Fertility Clinics for Third Year Running The California Center for Reproductive Health (CCRH), widely regarded as one of the premier fertility clinics in the country, has once…
Shearwater Health Achieves Great Place to Work® Status Globally
Shearwater Health Earns Great Place to Work® Certification Across U.S., Philippines, and India, Showcasing a Unified Commitment to Employee Well-Being Shearwater Health, a global leader in clinician-led clinical solutions, has proudly earned the esteemed Great Place to Work® Certification across…
Qualthera Health Launches Drug Repurposing Subsidiary
Qualthera Health Corporation Launches Qualthera Pharmaceuticals Ltd. Co. to Lead Innovation in Drug Repurposing and Targeted Delivery Qualthera Health Corporation, a leader in personalized medicine through its network of patient-centered compounding pharmacies, has announced the official launch of Qualthera Pharmaceuticals…
Edgewood Oncology Reports Promising Preclinical Efficacy Data for BTX-A51 in Investigator-Sponsored Liposarcoma Study
Edgewood Oncology Unveils Compelling Preclinical Data Supporting BTX-A51 in Liposarcoma at AACR Annual Meeting 2025 Edgewood Oncology, a clinical-stage biotechnology company dedicated to advancing targeted cancer therapies, today announced new preclinical efficacy data for BTX-A51 in liposarcoma (LPS). The data,…